6ELC image
Entry Detail
PDB ID:
6ELC
Keywords:
Title:
Crystal Structure of O-linked Glycosylated VSG3
Biological Source:
Source Organism:
PDB Version:
Deposition Date:
2017-09-28
Release Date:
2018-07-11
Method Details:
Experimental Method:
Resolution:
1.41 Å
R-Value Free:
0.16
R-Value Work:
0.13
R-Value Observed:
0.13
Space Group:
I 21 3
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Variant surface glycoprotein
Chain IDs:A
Chain Length:509
Number of Molecules:1
Biological Source:Trypanosoma brucei brucei
Ligand Molecules
Primary Citation
African trypanosomes evade immune clearance by O-glycosylation of the VSG surface coat.
Nat Microbiol 3 932 938 (2018)
PMID: 29988048 DOI: 10.1038/s41564-018-0187-6

Abstact

The African trypanosome Trypanosoma brucei spp. is a paradigm for antigenic variation, the orchestrated alteration of cell surface molecules to evade host immunity. The parasite elicits robust antibody-mediated immune responses to its variant surface glycoprotein (VSG) coat, but evades immune clearance by repeatedly accessing a large genetic VSG repertoire and 'switching' to antigenically distinct VSGs. This persistent immune evasion has been ascribed exclusively to amino-acid variance on the VSG surface presented by a conserved underlying protein architecture. We establish here that this model does not account for the scope of VSG structural and biochemical diversity. The 1.4-Å-resolution crystal structure of the variant VSG3 manifests divergence in the tertiary fold and oligomeric state. The structure also reveals an O-linked carbohydrate on the top surface of VSG3. Mass spectrometric analysis indicates that this O-glycosylation site is heterogeneously occupied in VSG3 by zero to three hexose residues and is also present in other VSGs. We demonstrate that this O-glycosylation increases parasite virulence by impairing the generation of protective immunity. These data alter the paradigm of antigenic variation by the African trypanosome, expanding VSG variability beyond amino-acid sequence to include surface post-translational modifications with immunomodulatory impact.

Legend

Protein

Chemical

Disease

Primary Citation of related structures